External validation of a claims-based model to predict left ventricular ejection fraction class in patients with heart failure

PLoS One. 2021 Jun 4;16(6):e0252903. doi: 10.1371/journal.pone.0252903. eCollection 2021.

Abstract

Background: Ejection fraction (EF) is an important prognostic factor in heart failure (HF), but administrative claims databases lack information on EF. We previously developed a model to predict EF class from Medicare claims. Here, we evaluated the performance of this model in an external validation sample of commercial insurance enrollees.

Methods: Truven MarketScan claims linked to electronic medical records (EMR) data (IBM Explorys) containing EF measurements were used to identify a cohort of US patients with HF between 01-01-2012 and 10-31-2019. By applying the previously developed model, patients were classified into HF with reduced EF (HFrEF) or preserved EF (HFpEF). EF values recorded in EMR data were used to define gold-standard HFpEF (LVEF ≥45%) and HFrEF (LVEF<45%). Model performance was reported in terms of overall accuracy, positive predicted values (PPV), and sensitivity for HFrEF and HFpEF.

Results: A total of 7,001 HF patients with an average age of 71 years were identified, 1,700 (24.3%) of whom had HFrEF. An overall accuracy of 0.81 (95% CI: 0.80-0.82) was seen in this external validation sample. For HFpEF, the model had sensitivity of 0.96 (95%CI, 0.95-0.97) and PPV of 0.81 (95% CI, 0.81-0.82); while for HFrEF, the sensitivity was 0.32 (95%CI, 0.30-0.34) and PPV was 0.73 (95%CI, 0.69-0.76). These results were consistent with what was previously published in US Medicare claims data.

Conclusions: The successful validation of the Medicare claims-based model provides evidence that this model may be used to identify patient subgroups with specific EF class in commercial claims databases as well.

Publication types

  • Research Support, Non-U.S. Gov't
  • Validation Study

MeSH terms

  • Aged
  • Cohort Studies
  • Databases, Factual*
  • Electronic Health Records
  • Female
  • Heart Failure / complications*
  • Heart Failure / physiopathology*
  • Humans
  • Insurance Claim Review / statistics & numerical data*
  • Male
  • Medicare
  • Stroke Volume*
  • United States / epidemiology
  • Ventricular Dysfunction, Left / diagnosis*
  • Ventricular Dysfunction, Left / epidemiology
  • Ventricular Dysfunction, Left / etiology

Grants and funding

This study was supported by a collaborative research grant from Novartis Inc. The study was conducted by the authors independent of the sponsor. The funder provided support in the form of salaries for authors AK, AB, RS and RL but did not have any additional role in the study design, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘Author contributions’ section.